Will Trump’s Free-Market Drug Pricing Solution Cut Out Greedy Middlemen?

An executive order instructs the HHS secretary to negotiate with drug manufacturers so that Americans pay the same low prices that others do.

Jill Biden’s $100 Million Women’s Health Initiative Won’t Make Up For The Ways This Administration Hurts Them

This administration has burdened women with many costs — costs that contribute to women remaining ignored, understudied, underfunded, and sick.

Have Lawmakers Found A Back Door To Extending Their Covid Tyranny?

A drug price transparency bill making its way through the Senate fails to protect against authorities accessing patient medical records.

Why Democrats Can’t Just Tack Drug Price Controls Onto Their ‘Infrastructure’ Bill

At a minimum, Democrats seem likely to have to rewrite their 'negotiation' legislation from scratch to address procedural concerns.